Cidara Therapeutics, Inc. (CDTX)

Cidara Therapeutics Revenue

Cidara Therapeutics had revenue of $302.00K in the twelve months ending March 31, 2025, down -98.33% year-over-year. In the year 2024, Cidara Therapeutics had annual revenue of $1.28M, down -94.52%.

• Revenue (ttm): $302.00K
• Revenue Growth: -98.33%
• P/S Ratio: 3,459.71
• Revenue / Employee: $7,947
• Employees: 38
• Market Cap: 1.06B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.28M	-22.01M	-94.52%
Dec 31, 2023	23.28M	-213.00K	-0.91%
Dec 31, 2022	23.50M	-26.08M	-52.60%
Dec 31, 2021	49.57M	37.51M	310.81%
Dec 31, 2020	12.07M	-8.85M	-42.30%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.